News | January 31, 2011

Cranial Immobilization System Receives CE Mark

Cranial Immobilization System Receives CE Mark

January 31, 2011 – A patient-specific cranial immobilization system has received the CE mark. The Fraxion head frame, by Elekta, helps ensure accuracy and precision in stereotactic radiation therapy of cancer targets in the brain and cranium. The Fraxion is the first to integrate all proven cranial immobilization options in a single system. "The advantage of Fraxion head fixation is that it is a stereotactic system that can be used for nearly any patient," says Meinhard Nevinny-Stickel, M.D., a radiation oncologist in the department of therapeutic radiology and oncology, Medical University Innsbruck in Austria. "The patient can be immobilized with a thermoplastic mask, with the proven vacuum mouthpiece, or even a combination of both systems. Precise repositioning is possible with easily accessible adjustment screws – which make it much easier to fixate the patient in the treatment room." The partial and full head thermoplastic masks provide alternative immobilization options for non-invasive setup, without compromising accuracy. Combining the thermoplastic mask with the vacuum mouthpiece increases flexibility in setup options, allowing optimal setup based on the patient's needs. It also features a target positioner, which provides accurate target localization for stereotactic planning, imaging and treatment. For more information: www.elekta.com

 

Related Content

Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...